Genopole, France’s leading biopark for life sciences research, and Amgen, a pioneer in medical biotech, have joined forces to co-organize the International Colloquium on Innovation. The objective of the event is to better understand
1- the organization of innovation systems throughout the world
2- the specificities of major innovation sectors and channels including
3- those of biomedical innovation
4- the role of regions in innovation with the goal of identifying best practices through concrete examples.
What public policy deliberations (national, regional, etc.) are needed to improve France’s innovation system ?
What are the factors and conditions of success for clusters with worldwide reach ?
What new organizational modes should be considered ?
What can be done to favor all forms of innovation and permit entities to development in close symbiosis with their markets ?
The colloquium’s broad spectrum of participants will seek to address these questions via their particular points of view and thus bring light to our vision of innovation.
The colloquium is intended for actors and stakeholders in innovation : researchers, entrepreneurs, elected officials and policy makers in innovation, physicians, pharmacists, pharmacologists, representatives of health policy institutions, associations, the media, etc.
1 rue de l’Internationale,
Presentations will be made in English or French (depending on the speaker) but simultaneous translation will be available in the two languages.
Nicole Chémali, Public Relations Director
Mildred Geslin, Assistant, Public Relations Directorate
Tel : +33 160 878 440
Fax : +33 160 873 500
GIP Genopole, Genopole Campus 1 - Bât 8,
Direction de la communication
5, rue Henri Desbruères
91030 Évry Cedex, France